A Study of the Efficacy and Safety of Semaglutide Injection in the Treatment of Type 2 Diabetes Mellitus
NCT05816057
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
476
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Interventions
BIOLOGICAL:
semaglutide injection
Sponsor
Hangzhou Jiuyuan Gene Engineering Co. Ltd.,